Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
Muecksch, F.; Weisblum, Y.; Barnes, C.; Schmidt, F.; Schaefer-Babajew, D.; Lorenzi, J.; Flyak, A.; DeLaitsch, A.; Huey-Tubman, K.; Hou, S.; Schiffer, C.; Gaebler, C.; Wang, Z.; Da Silva, J.; Poston, D.; Finkin, S.; Cho, A.; Cipolla, M.; Oliveira, T.; Millard, K.; Ramos, V.; Gazumyan, A.; Rutkowska, M.; Caskey, M.; Nussenzweig, M.; Bjorkman, P.; Hatziioannou, T.; Bieniasz, P.
Show abstract
Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six independent antibody lineages. As well as increased neutralization potency, antibody evolution changed pathways for acquisition of resistance and, in some cases, restricted the range of neutralization escape options. For some antibodies, maturation apparently imposed a requirement for multiple spike mutations to enable escape. For certain antibody lineages, maturation enabled neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses 98%
- Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies 98%
- Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class 97%
Similar papers in this journal
- Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants 97%
- Broadly neutralizing antibodies target the coronavirus fusion peptide 97%
- Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants 96%
Similar papers in this journal
- A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope 97%
- Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease 97%
- Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.